Five parallel groups, exploratory clinical trial to compare the efficacy of single dose levocetirizine 2.5 and 5 mg, cetirizine 5 mg and 10 mg to placebo in reducing symptoms of SAR [seasonal allergic rhinitis] in sensitive subjects exposed to ragweed pollen in a EEU [environmental exposure chamber].

Trial Profile

Five parallel groups, exploratory clinical trial to compare the efficacy of single dose levocetirizine 2.5 and 5 mg, cetirizine 5 mg and 10 mg to placebo in reducing symptoms of SAR [seasonal allergic rhinitis] in sensitive subjects exposed to ragweed pollen in a EEU [environmental exposure chamber].

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Feb 2017

At a glance

  • Drugs Levocetirizine (Primary) ; Cetirizine
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 06 Jun 2007 Status change from in progress to completed.
    • 30 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top